Consultation corner.  The latest on female sexual health.
Leonard R
LR
DeRogatis
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D018687:Antidepressive Agents, Second-Generation; D001284:Atrophy; D001562:Benzimidazoles / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003687:Dehydroepiandrosterone / Q000627:therapeutic use; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005782:Gels; D006801:Humans; D007989:Libido; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D010919:Placebos / Q000627:therapeutic use; D017698:Postmenopause; D011687:Purines / Q000627:therapeutic use; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use; D013739:Testosterone / Q000008:administration & dosage / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D014621:Vagina / Q000473:pathology; D014665:Vasodilator Agents / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D018687:Antidepressive Agents, Second-Generation; D001562:Benzimidazoles; D018765:Dopamine Uptake Inhibitors; D005782:Gels; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D010919:Placebos; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D016642:Bupropion; C098107:flibanserin; D013739:Testosterone; D003687:Dehydroepiandrosterone; D000068677:Sildenafil Citrate